AVA Genomics Consultancy ApS: Financial statements 2024
CVR: 37493678
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
AVA Genomics Consultancy ApS (CVR 37493678) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 433,207 and a net result of DKK 250,658 compared with DKK -37,139 the year before. Equity in the 2024 report amounted to DKK 233,622. The solvency ratio was 77%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 433,207
- Profit/Loss
- DKK 250,658
- Equity
- DKK 233,622
- Total Assets
- DKK 303,403
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 433 t. | 251 t. | 234 t. | 1 |
| 2023 | - | -37 t. | -37 t. | -17 t. | - |
| 2022 | - | -19 t. | -20 t. | 20 t. | - |
| 2021 | - | 34 t. | 25 t. | 35 t. | 1 |
| 2020 | - | -117 | -135 | 10 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout AVA Genomics Consultancy ApS
AVA Genomics Consultancy ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AVA Genomics and Breeding Consultancy IVS. The management consists of Haja Najeemudin Kadarmideen. The company is owned by Haja Najeemudin Kadarmideen. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 14,728 and a net result of DKK -4,294 compared with DKK -18,733 the year before. Equity in the 2026 report amounted to DKK 90,595.